(1S,3R)-ACPD, a metabotropic glutamate receptor agonist, enhances damage after global ischaemia

By Henrich-Noack P.   Reymann K.G.  

European Journal of Pharmacology, Vol. 365, Iss. 1, 1999-01 ,pp. : 55-58

Elsevier

Access to resources Recommend Favorite

Metabotropic glutamate receptor agonist (1S,3R-ACPD) increased frontal cortex dopamine release in aged but not in young rats

By Pintor A.   Tiburzi F.   Pezzola A.   Volpe M.T.  

European Journal of Pharmacology, Vol. 359, Iss. 2, 1998-10 ,pp. : 139-142

Elsevier

Access to resources Recommend Favorite

1S,3R-ACPD has cataleptogenic effects and reverses MK-801- and less pronounced, d,l-amphetamine-induced locomotion

By Kronthaler U.O.   Schmidt W.J.  

European Journal of Pharmacology, Vol. 316, Iss. 2, 1996-12 ,pp. : 129-136

Elsevier

Access to resources Recommend Favorite

Reduced long-term potentiation in the dentate gyrus of mGlu 1 receptor-mutant mice in vivo

By Bordi F.  

European Journal of Pharmacology, Vol. 301, Iss. 1, 1996-04 ,pp. : 15-16

Elsevier

Access to resources Recommend Favorite

Interleukin-1 inhibits a tetraethylammonium-induced synaptic potentiation in the rat dentate gyrus in vitro

By Coogan A.N.   O'Connor J.J.  

European Journal of Pharmacology, Vol. 374, Iss. 2, 1999-06 ,pp. : 197-206

Elsevier

Access to resources Recommend Favorite